In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Lee Philip Shulman, MD, FACOG, FACMG
The Anna Ross Lapham Professor and Chief
Division of Clinical Genetics
Feinberg School of Medicine of Northwestern University
Consulting Fees: Natera, Sequenom Inc., Sera
Commercial Interest Speakers Bureau: Sequenom Inc.
Contracted Research: Natera, Sequenom Inc.
Sheryl A. Kingsberg, PhD
Chief, Division of Behavioral Medicine
Department of OB/GYN
University Hospitals Cleveland Medical Center
Professor, Departments of Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
MacDonald Women’s Hospital
Consulting Fees: AMAG Pharmaceuticals, Dare, Emotional Brain, Endoceutics, Palatin, Strategic Science Technologies, Valeant Pharmaceuticals
Commercial Interest Speakers Bureau: AMAG Pharmaceuticals, Therapeutics MD Contracted Research: AMAG Pharmaceuticals, Endoceutics, Palatin
Ownership Interest: Viveve
David J. Portman, MD
Director Emeritus, Columbus Center for Women’s Health Research
Adjunct Instructor of Obstetrics and Gynecology
Ohio State University
Salary: Sermonix Pharmaceuticals
Consulting Fees: AMAG Pharmaceuticals, ITF
Commercial Interest Speakers Bureau: AMAG Pharmaceuticals
Ownership Interest: Sermonix Pharmaceuticals
- Barry A. Fiedel, PhD has nothing to disclose.
- Amanda Hilferty has nothing to disclose.
- Brian P. McDonough, MD, FAAFP has nothing to disclose.
- Ashley Rosenthal has nothing to disclose.
- Robert Schneider, MSW has nothing to disclose.